Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Intervention in Children and Adolescents with Obesity
2019-003940-61Phase 2Active
- Sponsor
- Region Uppsala
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metformin in obesity (3 arms), sponsored by Region Uppsala. Primary endpoint: Primary endpoint: BMI-SDS change (WHO) at 6 months. Started Oct 2020; status: active.
02
Drugs
metformin
03
Conditions
obesity
Beyond the preview
Go deeper on 2019-003940-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003940-61.